Metraipolis › archive › dc_b66fc38940fb
Mesoporous Silica Nanoparticles With Customized Drug Ratio/Loading for Effective Treatment of Gemcitabine-Resistant Pancreatic Tumors — Europe PMC PMID:42145464
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42145464
- DOI
- 10.1002/anbr.202500255
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-04T02:33:05.926Z
- SHA-256 of the archived text
797c50f025d035a4111f1f3ca55f631461417bd73d3a4c62a8a7fcce248cba8f- Stable URL of this page
https://metraipolis.com/documento/dc_b66fc38940fb
How to cite
Mesoporous Silica Nanoparticles With Customized Drug Ratio/Loading for Effective Treatment of Gemcitabine-Resistant Pancreatic Tumors — Europe PMC PMID:42145464 — Europe PMC (en), https://europepmc.org/article/MED/42145464 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b66fc38940fb (Metraipolis archive dc_b66fc38940fb, sha256 797c50f025d035a4111f1f3ca55f631461417bd73d3a4c62a8a7fcce248cba8f)
BibTeX
@misc{dcb66fc38940fb,
title = {Mesoporous Silica Nanoparticles With Customized Drug Ratio/Loading for Effective Treatment of Gemcitabine-Resistant Pancreatic Tumors — Europe PMC PMID:42145464},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42145464},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b66fc38940fb; sha256 797c50f025d035a4111f1f3ca55f631461417bd73d3a4c62a8a7fcce248cba8f},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42145464. Agents can read the archived copy with the MCP tool read_document.